BRÈVE

sur Evotec AG (NASDAQ:EVTCY)

Evotec SE Names Dr Christian Wojczewski New CEO

Evotec SE announced the appointment of Dr Christian Wojczewski as its new Chief Executive Officer, effective 1st July 2024. The decision was made by the Supervisory Board and follows a comprehensive selection process initiated in January. Dr Wojczewski will succeed Dr Mario Polywka, who has served as the interim CEO since January 2024 and is set to retire at the end of June.

Dr Wojczewski, with a background in chemistry and over two decades of management experience in the healthcare sector, notably served as CEO of Mediq and Linde Healthcare. Prof. Dr Iris Löw-Friedrich, Chairperson of the Supervisory Board, expressed confidence in Wojczewski's capabilities to lead and evolve Evotec, praising his track record in transforming healthcare companies. Dr Wojczewski expressed his enthusiasm for driving future developments at Evotec, a leader in end-to-end R&D services for the life sciences industry.

R. E.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Evotec AG